+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Is there a case for n-3 fatty acid supplementation in cystic fibrosis?



Is there a case for n-3 fatty acid supplementation in cystic fibrosis?



Current Opinion in Clinical Nutrition and Metabolic Care 8(2): 153-159



Purpose of review: This review evaluates our current knowledge on the association of fatty acid abnormalities in cystic fibrosis with the disease process, and makes a case for a well-designed clinical trial to evaluate the clinical efficacy of long chain n-3 fatty acids. Recent findings: It has long been known that cystic fibrosis patients exhibit fatty acid abnormalities, but these have not been well investigated in tissues affected by the disease.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 004214675

Download citation: RISBibTeXText

PMID: 15716793

DOI: 10.1097/00075197-200503000-00008


Related references

Polyunsaturated fatty acid supplementation reverses cystic fibrosis-related fatty acid abnormalities in CFTR-/- mice by suppressing fatty acid desaturases. Journal of Nutritional Biochemistry 26(1): 36-43, 2015

Fatty acid supplementation in cystic fibrosis. Monographs in Paediatrics 10: 1-4, 1979

Fatty acid alterations and n-3 fatty acid supplementation in cystic fibrosis. Prostaglandins Leukotrienes and Essential Fatty Acids 77(5-6): 309-318, 2007

A therapeutic trial of fatty acid supplementation in cystic fibrosis. Pediatrics 57(4): 474-479, 1976

Essential fatty acid deficiency and nutritional supplementation in cystic fibrosis. Journal of Pediatrics 141(2): 157-159, 2002

Prospective study of fatty acid supplementation over 3 years in patients with cystic fibrosis. Journal of Pediatric Gastroenterology and Nutrition 2(3): 434-438, 1983

Effect on renal function of essential fatty acid supplementation in cystic fibrosis. Journal of Pediatrics 115(2): 242-250, 1989

Essential fatty acid status in cystic fibrosis and the effects of safflower oil supplementation. American Journal of Clinical Nutrition 34(1): 1-7, 1981

A comprehensive evaluation of omega-3 fatty acid supplementation in cystic fibrosis patients using lipidomics. Journal of Nutritional Biochemistry 63: 197-205, 2019

Liver function and morphology during long-term fatty acid supplementation in cystic fibrosis. Liver. 14(1): 32-36, 1994

Fatty acids in blood and intestine following docosahexaenoic acid supplementation in adults with cystic fibrosis. Journal of Cystic Fibrosis 5(2): 77-84, 2006

Negative effects of oral fatty acid supplementation on sweat chloride in cystic fibrosis. Pediatrics 64(1): 50-52, 1979

Paradoxical effects of essential fatty acid supplementation on lipid profiles and sweat electrolytes in cystic fibrosis. British Journal of Nutrition 63(2): 259-271, 1990

An overview of monitoring and supplementation of omega 3 fatty acids in cystic fibrosis. Clinical Biochemistry 40(8): 511-520, 2007

Long chain fatty acid metabolism and essential fatty acid deficiency with special emphasis on cystic fibrosis. Bracco, U. And R. J. Deckelbaum (ed.). Nestle Nutrition Workshop Series, Vol. 28. Polyunsaturated Fatty Acids In Human Nutrition; Meeting, Mexico City, Mexico, November 27-30,. Xi 243p. Nestec Ltd: Vevey, Switzerland; Raven Press: New York, New York, Usa. Illus. 159-167, 1992